U.S. Auto Components Stock News

NYSE:AA
NYSE:AAMetals and Mining

Assessing Alcoa (AA) Valuation After Middle East Supply Disruptions And Aluminum Price Strength

Missile strikes on major Middle Eastern aluminum producers have pushed supply risk to the forefront, and Alcoa (AA) is suddenly back in focus as investors reassess global pricing power and potential margins. See our latest analysis for Alcoa. The recent jump in aluminum prices and supply concerns has fed directly into Alcoa’s share price momentum, with a 17.03% 7 day share price return, 24.82% 90 day share price return and a 1 year total shareholder return of 122.54%, suggesting that optimism...
NYSE:LH
NYSE:LHHealthcare

Should Labcorp’s Expanded Illumina Oncology Partnership Reshape the Precision Medicine Story for LH Investors?

In March 2026, Illumina and Labcorp expanded their precision oncology collaboration to develop and distribute next-generation sequencing-based cancer tests, including co-commercializing Labcorp's FDA-authorized PGDx elio plasma focus Dx liquid biopsy alongside Illumina's FDA-approved TruSight Oncology Comprehensive for solid tumors. This alliance aims to widen access to both tissue and liquid biopsy biomarker testing, support companion diagnostic development for drugmakers, and strengthen...
NYSE:BANC
NYSE:BANCBanks

A Look At Banc Of California’s (BANC) Valuation As Debt Redemption And Buybacks Take Center Stage

Redemption and Buyback Moves Put Capital Management in Focus Banc of California (BANC) drew investor attention after announcing plans to redeem $385 million of subordinated notes originally issued by Pacific Western Bank and to extend its share repurchase plan through March 16, 2027. See our latest analysis for Banc of California. The latest debt redemption and buyback announcements arrive after a 1-day share price return of 3.53% to US$17.58. However, the 90-day share price return of 8.86%...
NYSE:INSP
NYSE:INSPMedical Equipment

Is It Time To Reassess Inspire Medical Systems (INSP) After Its Steep Multi‑Year Share Price Slump

If you are wondering whether Inspire Medical Systems at around US$51.58 is starting to look interesting, the key question is how its current price stacks up against its underlying worth. The share price has been under pressure, with a 0.9% decline over the last week, a 20.0% decline over the last month, and a 44.1% decline year to date, adding to a 67.4% decline over the past year and 77.2% and 75.1% declines over the past three and five years respectively. These returns have kept Inspire...
NYSE:FLUT
NYSE:FLUTHospitality

Can Jefferies’ FanDuel Predicts Call Subtly Recast Flutter’s (FLUT) U.S. Betting Profit Narrative?

In late March 2026, Jefferies issued positive coverage on Flutter Entertainment, highlighting the FanDuel Predicts app’s strong download momentum and potential to add an estimated US$125.00 million in annual revenue that is not yet reflected in company guidance or market forecasts, even as regulatory scrutiny of prediction markets increases. An interesting angle is how UConn’s upset win over Duke underscored the way underdog victories can support sportsbook profitability, indirectly...
NYSE:APAM
NYSE:APAMCapital Markets

Is Artisan Partners (APAM) Still Attractive After Recent Share Price Weakness?

Wondering if Artisan Partners Asset Management at around US$36.39 is offering value right now, or if the easy money has already been made. The stock is up 1.6% over the last 7 days, although it shows a 9.7% decline over 30 days, a 12.1% decline year to date, and a 0.3% return over the past year, which may have shifted how investors see its risk and return profile. Recent coverage has focused on the stock’s mixed return picture, with a modest 0.3% 1 year return sitting alongside a 46.5%...
NasdaqGS:MAT
NasdaqGS:MATLeisure

A Look At Mattel (MAT) Valuation As Masters Of The Universe Rollout And Restructuring Take Shape

Mattel (MAT) is back in focus after unveiling a global Masters of the Universe product program tied to the 2026 live action film, alongside fresh layoffs at its El Segundo headquarters. See our latest analysis for Mattel. Despite the Masters of the Universe launch and ongoing restructuring, Mattel’s 30 day share price return decline of 14.28% and year to date share price return decline of 27.5% sit alongside a 1 year total shareholder return decline of 25.22%, pointing to fading momentum...
NasdaqGS:ALAB
NasdaqGS:ALABSemiconductor

Astera Labs (ALAB) Valuation Check After FTSE Index Inclusion And New Shelf Registration

Astera Labs (ALAB) has drawn fresh attention after being added to the FTSE All-World Index and filing a new shelf registration. This filing gives the company flexibility to issue up to US$704.8 million in common stock. See our latest analysis for Astera Labs. Astera Labs’ recent FTSE All-World Index inclusion and shelf registration come after a mixed price pattern, with a 9.30% 1 day share price return contrasting with weaker 30 day and year to date share price returns, while the 1 year total...
NYSE:FIX
NYSE:FIXConstruction

Comfort Systems USA (FIX) Joins FTSE All-World Index as Analysts Scrutinize Earnings Power and Backlog

Comfort Systems USA, Inc. (NYSE: FIX) was added to the FTSE All-World Index (USD) on 21 March 2026, further cementing its position among globally tracked construction and building-services companies. This index inclusion coincides with growing attention on the company’s upcoming fiscal Q1 2026 earnings, where analysts are looking for double-digit earnings growth and continued backlog strength. We’ll now examine how the FTSE All-World Index inclusion could influence Comfort Systems USA’s...
NYSE:ANF
NYSE:ANFSpecialty Retail

A Look At Abercrombie & Fitch’s (ANF) Valuation After Earnings Growth And Buybacks Fuel Recent Market Move

Abercrombie & Fitch (ANF) is drawing attention after operational improvements, including average comparable store sales growth of 10% over the past two years, a reported 62.8% gross margin and very large earnings per share growth supported by share repurchases. See our latest analysis for Abercrombie & Fitch. The recent 1-day share price return of 4.79% takes Abercrombie & Fitch to US$91.37. However, this sits against a 90-day share price return of negative 27.41% and a 1-year total...
NYSE:HIMS
NYSE:HIMSHealthcare

Did Hims & Hers' Novo Nordisk GLP-1 Partnership Just Shift Hims & Hers Health's (HIMS) Investment Narrative?

In March 2026, Hims & Hers Health announced a collaboration with Novo Nordisk to offer eligible customers a broad range of FDA-approved GLP-1 medications, including the Wegovy pill, alongside a new weight loss membership featuring 24/7 provider access and personalized support starting at US$39 for the first month and US$149 thereafter. This partnership expands Hims & Hers’ presence in the fast-growing medical weight management category by pairing branded GLP-1 therapies with a...
NYSE:MCO
NYSE:MCOCapital Markets

Is It Time To Reassess Moody's (MCO) After Recent Share Price Weakness?

This article walks through key numbers to help you judge whether Moody's current share price lines up with its underlying worth and if the stock looks expensive, cheap or somewhere in between. Moody's last closed at US$436.25, with returns of 1.8% over 7 days, an 8.7% decline over 30 days, a 12.6% decline year to date and a 6.2% decline over the last year. The 3 year and 5 year returns stand at 47.1% and 47.0% respectively. Recent coverage has focused on how Moody's performance over 3 and 5...
NasdaqGS:INTC
NasdaqGS:INTCSemiconductor

Intel (INTC) Valuation Check After Recent Share Price Momentum And Foundry Transition

Intel stock in focus Intel (INTC) is back in focus for investors after recent share price moves and fresh attention on its foundry and data center businesses, prompting a closer look at its current fundamentals and valuation. See our latest analysis for Intel. At a share price of US$44.13, Intel has seen a sharp 7.1% 1 day share price return, a 19.6% 90 day share price return, and a very large 1 year total shareholder return. This suggests momentum has recently strengthened after a softer 1...
NYSE:BRK.A
NYSE:BRK.ADiversified Financial

Berkshire Adds OxyChem As New Earnings Engine In Chemicals Expansion

Berkshire Hathaway has completed the acquisition of Occidental Petroleum's OxyChem subsidiary. The deal expands Berkshire's chemicals presence and supports Occidental's efforts to reduce debt and focus on energy operations. The transaction adds a new earnings stream within Berkshire's diversified portfolio under ticker NYSE:BRK.A. Berkshire Hathaway, trading under NYSE:BRK.A, is adding OxyChem to a portfolio that already spans insurance, energy, transportation and consumer businesses. The...
NasdaqGM:MDB
NasdaqGM:MDBIT

How MongoDB’s New CRO Hire to Lead Global Sales At MongoDB (MDB) Has Changed Its Investment Story

MongoDB, Inc. recently announced that outgoing Chief Revenue Officer Paul Capombassis will support a leadership transition through the second quarter of 2026, as Ryan Mac Ban, formerly CRO at Confluent, steps into the Chief Revenue Officer role effective April 27, 2026 to lead the global sales organization. This hire brings two decades of enterprise software sales experience into MongoDB’s go-to-market leadership at a time when the company is emphasizing its next phase of growth and...
NasdaqCM:POET
NasdaqCM:POETSemiconductor

The Bull Case For POET Technologies (POET) Could Change Following Major Funding And First Big Production Order

POET Technologies reported in the past that it had shifted from development to execution by securing more than US$225,000,000 in financing in 2025, adding a further US$150,000,000 in January 2026, and landing a production order above US$5,000,000 for its POET Infinity optical engines. This combination of large-scale funding and an initial multi-million-dollar production order highlights how POET is positioning its optical engine platform for commercial-scale manufacturing and customer...
NasdaqGM:RZLV
NasdaqGM:RZLVSoftware

Rezolve AI (RZLV) Revenue Surge To US$40.5 Million Tests Bearish Loss Concerns

Rezolve AI (RZLV) has just put fresh FY 2025 numbers on the table, with second half revenue of about US$40.5 million and a basic EPS loss of US$0.14, backed by trailing twelve month revenue of roughly US$46.8 million and a basic EPS loss of US$0.38. The company has seen revenue move from just US$0.1 million in the second half of FY 2024 to US$6.3 million in the first half of FY 2025 and then to US$40.5 million in the latest half, while basic EPS losses shifted from US$0.98 to US$0.25 and then...
NYSE:BKE
NYSE:BKESpecialty Retail

Is Buckle (BKE) Offering Value After Its Multi Year Share Price Surge

If you are wondering whether Buckle at around US$50.36 offers solid value or is pricing in too much optimism, this breakdown will help you frame that question clearly. The stock has had a mixed short term patch, with a 0.6% return over the last week, a 6.0% decline over the past month, and a 6.5% decline year to date, as well as a 42.9% return over the last year and 84.3% and 112.4% returns over the past 3 and 5 years. Recent coverage has focused on Buckle in the context of broader retail...
NYSE:CAH
NYSE:CAHHealthcare

Is Cardinal Health (CAH) Still Attractive After Recent Pullback And Strong Multi Year Gains

Wondering if Cardinal Health at around US$211 a share still offers value, or if most of the opportunity is already reflected in the price. The stock has returned 2.0% over the last week, seen a 7.8% decline over the last 30 days, yet is up 2.7% year to date and 55.8% over the past year, with very large gains over 3 and 5 years. Recent headlines have focused on Cardinal Health's broader role as a major healthcare distributor and solutions provider, which keeps attention on how its scale and...
NYSE:JOBY
NYSE:JOBYAirlines

Joby Test Flight Links Certification Progress To Future Air Taxi Revenue Potential

Joby Aviation (NYSE:JOBY) completed a test flight with its first conforming aircraft. The flight is a key step ahead of the company’s upcoming FAA Type Inspection Authorization certification. This milestone marks progress toward regulatory approval for future commercial operations. Joby Aviation, listed on the NYSE under the ticker JOBY, focuses on electric vertical take off and landing aircraft intended for short haul passenger trips. The recent test flight with a conforming aircraft comes...
NasdaqGS:BIDU
NasdaqGS:BIDUInteractive Media and Services

The Bull Case For Baidu (BIDU) Could Change Following Its ERNIE-Led AI And Digital Human Pivot

Baidu recently highlighted its evolution from a traditional search provider into an AI-centered technology platform, anchored by its ERNIE foundation model and Baidu Cloud, which now support a broad suite of multimodal AI applications for Chinese enterprises. A particularly distinctive development is Baidu’s use of Digital Human technology to automate marketing, sales, and customer engagement, signaling a push toward AI-native business operations across its ecosystem. We’ll now examine how...
NYSE:CB
NYSE:CBInsurance

Does Safe Harbor’s Exclusive Marine Deal Deepen Chubb’s Niche Strategy Or Narrow Its Opportunities (CB)?

In March 2026, Safe Harbor Marinas announced an exclusive partnership naming Chubb as the preferred insurance provider for members across more than 150 marinas, giving them access to Chubb’s Masterpiece Select Recreational Marine Insurance with wide-ranging coverage features. This deal highlights how Chubb is using specialized products, such as high-end recreational marine policies, to deepen reach in niche insurance segments with targeted customer bases. We’ll now examine how this...
NasdaqGS:TSEM
NasdaqGS:TSEMSemiconductor

Assessing Tower Semiconductor (NasdaqGS:TSEM) Valuation As GlobalFoundries Lawsuits Put Future Growth In Focus

GlobalFoundries has filed multiple U.S. lawsuits accusing Tower Semiconductor (TSEM) of infringing 11 patents related to high performance chip manufacturing processes, and is seeking to block the importation and sales of certain Tower products. See our latest analysis for Tower Semiconductor. The legal action has arrived after a strong run, with a 1 month share price return of 40.53% and a 1 year total shareholder return of more than 4x. However, the 7 day share price return of 2.95% suggests...
NYSE:MHO
NYSE:MHOConsumer Durables

A Look At M/I Homes (MHO) Valuation After Recent Share Price Volatility

M/I Homes (MHO) has been drawing attention after recent share price swings, with the stock up about 3.2% on the day but showing a 13.9% decline over the past month. See our latest analysis for M/I Homes. That 3.2% 1 day share price gain comes after a 13.9% 30 day share price decline and a mildly negative year to date share price return. However, the 3 year total shareholder return near 100% and 5 year total shareholder return near 96% highlight how longer term holders have still seen strong...